Compounds for Treatment of diseases associated with Amyloid Proteins or Amyloid type； Pharmaceutical composition that comprises； the use of compound to retain or increase the memory Week 3VAT.
KROTH HEIKO,HAMEL COTINICA,BENDERITTER PASCAL,FROESTL WOLFGANG,SREENIVASACHARY NAMPALLY,MUHS ANDREAS
申请号：
CL2012002896
公开号：
CL2012002896A1
申请日:
2012.10.16
申请国别(地区):
CL
年份:
2013
代理人:
摘要：
The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.“COMPUESTOS DERIVADOS DE HETEROCICLOS NITROGENADO； COMPOSICIÓN FARMACÉUTICA QUE LOS COMPRENDE； COMBINACIÓN FARMACÉUTICA, MÉTODO IN VITRO； KIT DE DIAGNÓSTICO； USO EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADA CON PROTEÍNA AMILOIDE Ó TIPO AMILOIDE, TALES COMO ALZHEIMER, SÍNDROME DE DOWN, PROBLEMAS OCULARES, ENTRE OTRAS”. PCT
